Investigative ophthalmology & visual science · 2026
Macular Pigment and Retinal Reflectance in a Feasibility Study of Multiple Sclerosis: Toward Novel Biomarkers of Hidden Disease Processes.
СтатьяНаблюдательное исследованиеПоддержка исследования: вне правительства СШАНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Mitchell Jamie, Sloan Kenneth, Hogg Ruth, McIlwaine Gemma, Coey Rachel, Steen Jason, Fitzgerald Denise C, Moffat Jill, Hughes Stella, McDonell Gavin, Peto Tunde, Lengyel Imre, Csincsik Lajos
Аннотация
PURPOSE: To evaluate the feasibility and characteristics of macular pigment optical density (MPOD) and retinal reflectance (RR) measurements using two-wavelength autofluorescence (AF) and multicolor imaging, respectively, in multiple sclerosis (MS), and explore differences compared with healthy controls. Sixteen MS participants and 25 age-matched healthy controls were included in this prospective, observational, single-center, cross-sectional, feasibility study.
METHODS: After pupil dilation, blue- and green-light fundus autofluorescence and multicolor imaging were performed using the Heidelberg Spectralis. Custom-built ImageJ plugins extracted MPOD, spatial profiles, macular pigment optical volume (MPOV), and hyperspectral indexes (HSI) from RR. Linear mixed-effects models compared outcomes between MS eyes with optic neuritis (MSON), without optic neuritis (MSnON), and controls. A post hoc power analysis characterized detectable effect sizes given the available sample size.
RESULTS: MPOD and RR were successfully measured in all participants. Macular pigment spatial profiles differed between MS and controls (P = 0.010). Ring-like MPOD patterns were observed in 43% of MS eyes and were most pronounced in MSON (67%). HSI varied regionally (P < 0.001) but was not associated with MS status. MPOV did not differ significantly between groups. MPOD demonstrated inter-individual variability within both groups. Exploratory analyses showed that higher peripheral MPOD (3°-6°) was associated with greater inner/full retinal thickness, whereas higher HSI was associated with thinner outer retina and smaller foveal avascular zone volume (all P ≤ 0.05).
CONCLUSIONS: AF-based MPOD measurement is feasible in MS, providing spatially resolved, objective macular pigment quantification. AF-derived MPOD showed limited sensitivity to MS-related changes in isolation. Larger cohort studies with multimodal retinal imaging are required to determine MPOD's role as a biomarker in MS.
METHODS: After pupil dilation, blue- and green-light fundus autofluorescence and multicolor imaging were performed using the Heidelberg Spectralis. Custom-built ImageJ plugins extracted MPOD, spatial profiles, macular pigment optical volume (MPOV), and hyperspectral indexes (HSI) from RR. Linear mixed-effects models compared outcomes between MS eyes with optic neuritis (MSON), without optic neuritis (MSnON), and controls. A post hoc power analysis characterized detectable effect sizes given the available sample size.
RESULTS: MPOD and RR were successfully measured in all participants. Macular pigment spatial profiles differed between MS and controls (P = 0.010). Ring-like MPOD patterns were observed in 43% of MS eyes and were most pronounced in MSON (67%). HSI varied regionally (P < 0.001) but was not associated with MS status. MPOV did not differ significantly between groups. MPOD demonstrated inter-individual variability within both groups. Exploratory analyses showed that higher peripheral MPOD (3°-6°) was associated with greater inner/full retinal thickness, whereas higher HSI was associated with thinner outer retina and smaller foveal avascular zone volume (all P ≤ 0.05).
CONCLUSIONS: AF-based MPOD measurement is feasible in MS, providing spatially resolved, objective macular pigment quantification. AF-derived MPOD showed limited sensitivity to MS-related changes in isolation. Larger cohort studies with multimodal retinal imaging are required to determine MPOD's role as a biomarker in MS.